Cargando…

Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody

BACKGROUND: Presence of isolated anti-HBc antibody is common in HIV-infected patients in endemic areas and could be caused by prior HBV infection with loss of anti-HBs antibody. The role of vaccination in these patients remains controversial and is based largely on limited and low quality data. We,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laksananun, Nattinee, Praparattanapan, Jutarat, Kotarathititum, Wilai, Supparatpinyo, Khuanchai, Chaiwarith, Romanee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498566/ https://www.ncbi.nlm.nih.gov/pubmed/31053142 http://dx.doi.org/10.1186/s12981-019-0225-3

Ejemplares similares

2238. Immunogenicity and safety of four- vs. three-standard doses HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
por: Laksananun, Nattinee, et al.
Publicado: (2018)

Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial
por: Chaiwarith, Romanee, et al.
Publicado: (2019)

Comparison of Immunogenicity and Safety of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: A Randomized, Controlled Trial
por: Chaiklang, Kanokporn, et al.
Publicado: (2013)

2231. Long-Term Immunogenicity of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: An Extension of a Randomized Controlled Trial
por: Chaiwarith, Romanee, et al.
Publicado: (2018)

Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand
por: Chaiwarith, Romanee, et al.
Publicado: (2016)

Hepatitis B Vaccination Induced TNF-α- and IL-2-Producing T Cell Responses in HIV− Healthy Individuals Higher than in HIV+ Individuals Who Received the Same Vaccination Regimen
por: Chawansuntati, Kriangkrai, et al.
Publicado: (2018)

Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains
por: Yasamut, Umpa, et al.
Publicado: (2019)

Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: a retrospective study
por: Kawila, Rathakarn, et al.
Publicado: (2013)

Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand
por: Khienprasit, Nitta, et al.
Publicado: (2011)

Autoantibody to Interferon-gamma Associated with Adult-Onset Immunodeficiency in Non-HIV Individuals in Northern Thailand
por: Wongkulab, Panuwat, et al.
Publicado: (2013)

Streptococcus agalactiae in adults at chiang mai university hospital: a retrospective study
por: Chaiwarith, Romanee, et al.
Publicado: (2011)

365. Neurocognitive Function Change after Switching from Efavirenz to Rilpivirine in HIV-Infected Adults: A Randomized Control Trial
por: Kaewpoowat, Quanhathai, et al.
Publicado: (2019)

Proteomic Analysis of Serum and Urine of HIV-Monoinfected and HIV/HCV-Coinfected Patients Undergoing Long Term Treatment with Nevirapine
por: Wongtrakul, Jeerang, et al.
Publicado: (2014)

Immune Alterations in Patients with Anti-Interferon-γ Autoantibodies
por: Chruewkamlow, Nuttapol, et al.
Publicado: (2016)

2145. Carbapenem-Resistant Enterobacteriaceae infections at the Maharaj Nakorn Chiang Mai Hospital
por: Chaiwarith, Romanee, et al.
Publicado: (2019)

Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand
por: Hongjaisee, Sayamon, et al.
Publicado: (2023)

Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
por: Chaiwarith, Romanee, et al.
Publicado: (2023)

Cellular Immune Responses in HIV-Negative Immunodeficiency with Anti-Interferon-γ Antibodies and Opportunistic Intracellular Microorganisms
por: Wipasa, Jiraprapa, et al.
Publicado: (2014)

Comparison of Xpert MTB/RIF Assay and the Conventional Sputum Microscopy in Detecting Mycobacterium tuberculosis in Northern Thailand
por: Pinyopornpanish, Kanokwan, et al.
Publicado: (2015)

Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Populations
por: Sudjaritruk, Tavitiya, et al.
Publicado: (2023)

First Isolation of Leishmania from Northern Thailand: Case Report, Identification as Leishmania martiniquensis and Phylogenetic Position within the Leishmania enriettii Complex
por: Pothirat, Thatawan, et al.
Publicado: (2014)

Isolated Anti-HBc and Occult HBV Infection in Dialysis Patients
por: Ramezani, Amitis, et al.
Publicado: (2014)

Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients
por: Sakkhachornphop, Supachai, et al.
Publicado: (2018)

Evaluation of Blood Units with Isolated Anti HBC for the Presence of HBV DNA
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2002)

Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene
por: Kim, Myeong Hee, et al.
Publicado: (2017)

Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA
por: Petrovskis, Ivars, et al.
Publicado: (2021)

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
por: Cerva, Carlotta, et al.
Publicado: (2022)

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
por: Masarone, Mario, et al.
Publicado: (2014)

Appropriate Time to Start Antiretroviral Therapy in HIV-infected Patients with Penicilliosis marneffei
por: Utkham, Thongchai, et al.
Publicado: (2017)

Seroprevalence of anti-HBc, risk factors of occupationally acquired HBV infection and HBV vaccination among hospital staff in Poland: a multicenter study
por: Ganczak, Maria, et al.
Publicado: (2019)

Anti‐HBc‐nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults
por: Deng, Xuelian, et al.
Publicado: (2022)

The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts
por: Holtkamp, Caroline, et al.
Publicado: (2022)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
por: Lan, Ting-Yuan, et al.
Publicado: (2023)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
por: Lalwani, Sanjay K., et al.
Publicado: (2016)

Anti-HBc IgG Responses Occurring at the Early Phase of Infection Correlate Negatively with HBV Replication in a Mouse Model
por: Wang, Xuyang, et al.
Publicado: (2022)

RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy
por: Ergenç, İlkay, et al.
Publicado: (2023)

A Cluster Randomized Controlled Trial Comparing Early and Late Carbapenems De-escalation in the Medicine Units, Maharaj Nakorn Chiang Mai Hospital
por: Eiamparpai, Prot, et al.
Publicado: (2017)

Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
por: Teekaput, Chutithep, et al.
Publicado: (2023)

1271. Antimicrobial Appropriateness after Ambulatory Antimicrobial Stewardship Program for Uncomplicated Cystitis
por: Thongwitokomarn, Harit, et al.
Publicado: (2023)

Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants
por: Niyomnaitham, Suvimol, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u1vmfldvuf9kh29fgetkf06e7b